JP2005526745A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526745A5
JP2005526745A5 JP2003572956A JP2003572956A JP2005526745A5 JP 2005526745 A5 JP2005526745 A5 JP 2005526745A5 JP 2003572956 A JP2003572956 A JP 2003572956A JP 2003572956 A JP2003572956 A JP 2003572956A JP 2005526745 A5 JP2005526745 A5 JP 2005526745A5
Authority
JP
Japan
Prior art keywords
azaspiro
hydrogen
alkyl
group
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003572956A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526745A (ja
Filing date
Publication date
Priority claimed from DE10210190A external-priority patent/DE10210190A1/de
Application filed filed Critical
Publication of JP2005526745A publication Critical patent/JP2005526745A/ja
Publication of JP2005526745A5 publication Critical patent/JP2005526745A5/ja
Pending legal-status Critical Current

Links

JP2003572956A 2002-03-07 2003-02-27 痛みを治療するためのアザスピロ化合物 Pending JP2005526745A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10210190A DE10210190A1 (de) 2002-03-07 2002-03-07 Aza-Spiroverbindungen
PCT/EP2003/001986 WO2003074486A1 (de) 2002-03-07 2003-02-27 Aza-spiroverbindungen zur behandlug von schmerzen

Publications (2)

Publication Number Publication Date
JP2005526745A JP2005526745A (ja) 2005-09-08
JP2005526745A5 true JP2005526745A5 (https=) 2006-04-13

Family

ID=27771112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003572956A Pending JP2005526745A (ja) 2002-03-07 2003-02-27 痛みを治療するためのアザスピロ化合物

Country Status (19)

Country Link
US (1) US20050288351A1 (https=)
EP (2) EP1520854A3 (https=)
JP (1) JP2005526745A (https=)
KR (1) KR20040091638A (https=)
CN (1) CN1324011C (https=)
AT (1) ATE298745T1 (https=)
AU (1) AU2003215603A1 (https=)
BR (1) BR0307922A (https=)
CA (1) CA2477124A1 (https=)
DE (2) DE10210190A1 (https=)
ES (1) ES2242944T3 (https=)
MX (1) MXPA04008669A (https=)
NO (1) NO20044239L (https=)
PL (1) PL372431A1 (https=)
PT (1) PT1485352E (https=)
RU (1) RU2322438C2 (https=)
UA (1) UA78987C2 (https=)
WO (1) WO2003074486A1 (https=)
ZA (1) ZA200406245B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201607923A (zh) * 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環(4.5)癸烷衍生物
CN107216335B (zh) * 2017-06-29 2019-04-30 上海药明康德新药开发有限公司 一种叔丁基1-(羟甲基)-3-氧杂-9-氮杂螺[5.5]十一烷-9-甲酸基酯制法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2866734A (en) * 1956-12-05 1958-12-30 Us Vitamin Corp 3-pyridylethyl 2, 4-oxazolidinediones and process
US3150143A (en) * 1960-07-19 1964-09-22 Geschicketer Fund For Medical Therapeutically active nu-substituted azaspiranes
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
US3629276A (en) * 1969-07-16 1971-12-21 Abbott Lab 2-amino-5-spiro-substituted-oxazo compounds
US4430335A (en) * 1983-02-09 1984-02-07 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1-azaspiro[4,5]decanes and their analgesic compositions
GB8916447D0 (en) * 1989-07-19 1989-09-06 Ici Plc Composition,process and use
US5319135A (en) * 1989-08-25 1994-06-07 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
US5132451A (en) * 1989-08-25 1992-07-21 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
RU95114363A (ru) * 1992-11-09 1997-03-20 Дзе Бутс Компани ПЛС. (GB) Производные азаспиросоединений, способ их получения, фармацевтическая композиция, средства для лечения ожирения, средства для лечения аффективных расстройств
US5925672A (en) * 1996-12-06 1999-07-20 Neurosciences Research Foundation, Inc. Methods of treating mental diseases, inflammation and pain
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
DE19732928C2 (de) * 1997-07-31 2000-05-18 Gruenenthal Gmbh Verwendung substituierter Imidazolidin-2,4-dion-Verbindungen als Schmerzmittel
US5948807A (en) * 1997-09-03 1999-09-07 Regents Of The University Of Minnesota Spiroindanamines and Spiroindanimides
DE19751062A1 (de) * 1997-11-18 1999-07-08 Univ Ludwigs Albert An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels
WO1999061424A1 (en) * 1998-05-26 1999-12-02 Warner-Lambert Company Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel

Similar Documents

Publication Publication Date Title
RU2401658C2 (ru) Гетероциклические ингибиторы аспартилпротеазы
JP2011521911A5 (https=)
JP2021534124A5 (https=)
JP2005531516A5 (https=)
JP2011502958A5 (https=)
JP2011520906A5 (https=)
JP2018511616A5 (https=)
JP2009533410A5 (https=)
JP2004175807A5 (https=)
RU2009102535A (ru) Производные карбамидов тропана, их получение и их применение в терапии
JP2011518163A5 (https=)
JP2007519649A5 (https=)
JP2018516238A5 (https=)
JP2018519245A5 (https=)
JP2013533317A5 (https=)
JP2005536475A5 (https=)
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
RU2009133259A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
JP2005539088A5 (https=)
JP2006501202A5 (https=)
TNSN06377A1 (en) Combinations of glycopyrrolate and beta2 adrenoceptor agonists
JP2002523400A5 (https=)
CA2539349A1 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
JP2005526696A5 (https=)
RU2006130000A (ru) Органические соединения